VCBeat Health Contact Us
Home Guoshengtang Files for IPO Amid Expansion of AI TCM Ecosystem and Industry-Wide Innovations

Guoshengtang Files for IPO Amid Expansion of AI TCM Ecosystem and Industry-Wide Innovations

Aug 04, 2025 18:31 CST Updated 18:31
WE-LINKING

Developer of Medical-Grade Fully Implantable Wireless Brain-Computer Interface Systems

Image
#Headlines Summary
Weekly Hot News

01
Brand News

    • Mindray Medical Park Officially Opens, with a Total Investment of 4.5 Billion Yuan

    • Singapore's Perennial Group Establishes a Large Hospital with 500 Beds in Shanghai

    • GUSHENGTANG HOLDINGS LIMITED Releases 10 National Medical AI Avatars, Accelerating the Construction of TCM AI Commercial Matrix

    • 1 Billion! A Major Move by the CRRC Group

    • "Largest AI TCM Clinic" Wenzhi Medicine Submits Listing Application to HKEX

    • Baidu Health Joins Hands with 100,000 Doctors to Create Over 100 Million AI Science Popularization Contents

    • Dr. Zhang Qiang Group Expands Overseas Medical Services, Accelerates Specialized Disease Center Layout Across China

    • Zhizhen Health Partners with Jiuzhou Tong to Build a Frontline Defense for Early Screening of Chronic Diseases

    • Nearly 1 Billion Yuan in Funding: Another Large Cancer Hospital is Coming!

    • Trump Announces Medical Technology Development Plan, Utilizing AI to Build an Intelligent Healthcare Ecosystem

    • GUSHENGTANG HOLDINGS LIMITED Partners with Meituan to Offer Exclusive Health Care for Delivery Riders

      02
      Policy Guidance

      • NHSA Releases: Immediate Settlement of Medical Insurance Funds

      • Four Departments Jointly Issue: Notice on Regulating "Self-Media" Medical Science Communication Behavior

      • Notice on Standardizing the Management of Outpatient Department Names in Medical Institutions Issued by Three Departments Including the National Health Commission

      • Financial Regulatory Authority Requires Urban Commercial Medical Insurance to Adhere to Commercial Nature, Standardize and Precisely Price

      • China's National Healthcare Security Administration Confirms "New Drug Launch Pricing Mechanism" for the First Time

      03
      Industry Dynamics
      • WE-LINKING Releases the World's First Customization Platform for Medical-Grade Implantable Brain-Computer Interface Systems
      • Mayo Clinic Partners with NVIDIA to Deploy Supercomputing Power, Accelerating the Development of Large Medical Models
      • Methuselah Completes Over 100 Million Yuan in B+ Round Financing, Boosting R&D and Commercialization of Medical Nutrition Products

      • Innary Medical Secures Tens of Millions in Pre-A Funding, Accelerating the Domestic Production Process of Bone Metabolism Diagnosis and Treatment in China
      04
      Selection Recommendation
      Overall Solution for Clinic Medical Space Design
      One-Stop Information Service for Clinics
      Image
      【Mindray Medical Industrial Park Officially Opens, with a Total Investment of 4.5 Billion Yuan】

      Recently,MINDRAYWE-LINKING Announces the Official Opening of Its Industrial Park in Jiangsu, Total InvestmentResourcesUp to 4.5 billion yuan. The completion of the industrial park marks Mindray's further expansion and strategic layout in the medical device field. The park will coverResearch and Development, Production, Sales...and other aspects, aiming to enhanceThe Comprehensive Competitiveness of Mindray Medical, Promote the innovation and development of the medical device industry.(Medical Device Innovation Network News)

      Image

      【Singapore's Perennial Group Layouts a Large Hospital with 500 Beds in Shanghai】】

      Recently, SingaporePengrui LiThe group announced that it has reached a strategic cooperation agreement with the LuJiaZui Management Bureau of China (Shanghai) Pilot Free Trade Zone Administrative Committee and Shanghai Lujiazui (Group) Co., Ltd., planning to establish a foreign-invested medical investment company in the Lujiazui area of Shanghai., to build a large-scale, wholly foreign-owned tertiary general hospital in Shanghai——Shanghai Perennial Hospital.The hospital plans for 500 beds, with an investment of 500 million yuan., will be built according to international standards, integrating advanced medical technology with international service concepts, and introducing outstanding medical expert teams from both within and outside China.Focus on building specialized treatment centers for orthopedics, cancer prevention and treatment, cardiovascular diseases, and otolaryngology.Pan Xi Yuan, Executive Chairman and CEO of Perennial Group, said that the group has a long-term positive outlook on China's healthcare market, and Shanghai Perennial Hospital will serveLocal residents and foreign nationals in Shanghai, and develop innovative medical tourism products to attract international high-net-worth individuals.(Medical News)

      Image

      【GUSHENGTANG HOLDINGS LIMITED Releases 10 National Medical AI Avatars, Accelerating the Construction of a TCM AI Business Matrix】

      August 1,GUSHENGTANGOfficially Release 10 National Medical AI Avatars, CoveringOncology, Dermatology, GastroenterologyIn eight major core TCM specialty fields. These AI avatars are built based on the clinical experience of 10 renowned doctors and canEnough to assist experts in handling routine diagnosis and treatment affairs, improve the efficiency of diagnosis and treatment,And helpYoung Doctors Rapid DevelopmentLong. GUSHENGTANG HOLDINGS LIMITED through “AI Pre-diagnosis + Expert Decision-makingThe human-machine collaboration model, launched"Online Follow-up Consultation"Services to alleviate the scarcity of high-quality Traditional Chinese Medicine (TCM) resources while achieving commercial implementation. The company plans to continuously expand its renowned physician network, building an AI Internet TCM hospital ecosystem centered on human-machine collaboration to drive innovation in TCM service models.(GUSHENGTANG HOLDINGS LIMITED Main Message)

      Image

      【1 Billion! Major Move by CR Group】

      Recently,CRPharmaceutical Group Announces That Multiple Listed Subsidiaries Will Collaborate with ShanghaiFOSUNPharmaceuticals and Chengdu-related enterprises jointly established CR Pharmaceutical (Chengdu) Innovation Investment Fund,The fund size has reached 1 billion yuan.The fund will mainly engage in equity investment, with a focus on investing in chemical innovative drugs, biologics (including vaccines), high-end medical devices (including IVD),TCM Tonic Category, and enterprises in fields such as synthetic biology.Huachrun Group companies invested 257.5 million yuan, accounting for 25.75%; Chengdu state-owned enterprises invested 642.5 million yuan, accounting for 64.25%.%；Fosun Pharma Invests 100 Million Yuan, Accounting for 10%.This fund establishment is a key step for CR Pharmaceutical to improve its industrial layout, aiming to acquire critical innovative assets and core technology platforms through external mergers and acquisitions, thereby promoting its rapid development in the field of innovative pharmaceuticals and medical devices.(CPhI China News)

      【"Largest AI TCM Clinic" Wenzhen TCM Submits Listing Application to HKEX】

      Recently,WENZHI TCMTCMTech Inc Updates Prospectus on HKEX. The company claims to be the largest AI-assisted Traditional Chinese Medicine healthcare service provider in China in 2024.But the market share is only 1.3%.2022-2024Wen Zhi Chinese Medicine's revenue was 0.62 billion yuan, 1.89 billion yuan, and 2.36 billion yuan, respectively, with losses during the same periods of 1.54 billion yuan, 1.94 billion yuan, and 0.45100 million yuan, with a total loss of approximately 393 million yuan over three years.Its main revenue sources are Chinese medical services, Chinese lifestyle products, and "Chinese Medicine Brain" subscription services. The "Chinese Medicine Brain" system of Wenzhen Chinese Medicine has accumulated over 100 million parameters and 10,000 prescriptions, covering more than 3,000 types of diseases. The company hopes to address issues such as the limited standardization of Chinese medical services and the scarcity of senior Chinese medicine practitioners through this system.(Economic Observer Network News)


      【Baidu Health Joins Hands with 100,000 Doctors to Create Over 100 Million AI Science Popularization Contents】】


      Recently,BaiduGUSHENGTANG HOLDINGS LIMITED announced the launch of the "Man Tian Xing Public Welfare Plan" on July 30.Collaborate with 100,000 doctors to build over 100 million authoritative AIGC-based science communication contents, creating100A leading expert IP, and create digital avatars for 1000 doctors free of charge.The plan also opens up the foundational capabilities of Baidu Health's large model, collaborating with medical schools and research institutions to build industry-specific large models. Through the "AIGC Review of Authoritative Science Popularization" initiative, Baidu Health adopts a three-tier review mechanism (AI examiner for intelligent screening, professional team for manual verification, external doctor experts for final review) to directly address the "hallucination problem" in the medical AI industry, enhancing the accuracy of health information.(Health Triumph News)

      Image

      [Dr. Zhang Qiang Medical Group Expands Overseas, Accelerates the Layout of Special Disease Centers Across China]】


      Recently,DOCTOR ZHANG QIANG GROUPComprehensively Expanding into the U.S. Market, the construction of the first CHIVA center is underway. Meanwhile,The group plans to complete CHIV within two years.In ChinaFull coverage of all provincial administrative regions in China.Dr. Zhang Qiang Medical Group has gone through three stages: 1.0 (asset-light), 2.0 (materialization), and 3.0 (chain-based), and is now accelerating into the 4.0 (globalization) new era. In the United States, the group adopts the PLLC (Professional Limited Liability Company) model, with a core team composed of vascular specialists licensed in the U.S., promoting cooperation through standardized service agreements. In addition, Dr. Zhang Qiang Medical Group also plans to use the MSO (Medical Management Service Organization) model.Provide brand authorization and operation management support for the Chinese market, promoting the standardized development of specialized disease centers.。(Medical Community News)


      Image


      【ZhiZhen Health Partners with Jiuzhou Tong to Build a Frontline Defense for Early Screening of Chronic Diseases】

      Recently,ZHI ZHEN HEALTHAndJIUZHOUTONGThe group has reached a deep cooperation,Jointly PromoteEarly Screening for Chronic Diseases at the Grassroots LevelBoth parties will utilize AI-based early screening technology for eye diseases to address the shortage of medical resources at the grassroots level, establishing a comprehensive health service circle for elderly chronic disease management within local communities and clinics. Zhen Health's self-developed 【Wutong】Silver Hair Health Management Service Platform, centered on an AI-driven health large model, offers full-process health services for the elderly. As a comprehensive service provider in the entire pharmaceutical industry chain, Joincare Pharmaceutical will leverage its robust market coverage and service capabilities.Promote AI Health Screening in Grassroots Communities, Clinics, Elderly Care Service Agencies, Pharmacies, etc.MoreApplication of Meta-scenarios.This collaboration aims to enhance the health and quality of life for elderly people at the grassroots level and promote healthy aging.(ToTrue Health News)

      【Nearly 1 Billion Investment, Another Large Tumor Hospital is Coming!】

      Recently, the Jiangsu Provincial Health Commission issued a public notice, proposing to approve the establishment of"Jurong Yiyou Cancer Hospital". This project is invested and constructed by YIYOU Health Management (Jiangsu) Co., Ltd.,With a total investment of 963 million yuan, it is positioned as a tertiary-level oncology specialty hospital, with a planned capacity of 400 beds.The hospital plans to open departments such as Oncology, Radiation Therapy, Pathology, and Medical Imaging. In recent years,With the survival of cancer patients...Survival RateThe continuous growth in the market space and development potential of tumor medical services has attracted the attention of multiple social capital entities.(Medical Community News)

      Image

      [Trump Announces Medical Technology Development Plan, Using AI to Build an Intelligent Healthcare Ecosystem]

      Recently, Trump announced a new medical technology development plan, aiming toUsing technologies such as artificial intelligence (AI) to build a patient-centered intelligenceCan, safe, personalized medical ecosystemThe program was announced at the "Make Medical Technology Great Again" conference, attended by prominent figures such as U.S. President Donald Trump, U.S. Secretary of Health and Human Services Kennedy Jr., CMS Administrator Mehmet Oz, and David O. Sacks, the White House AI and cryptocurrency lead. Amazon, Apple, Google, OpenAI, Anthropic, Cleveland Clinic, etc.More than 60 companies in the technology and healthcare sectors have committed to jointly advancing this initiative, with plans to deliver results in the first quarter of 2026.(Intelligence Pharmacy Bureau News)

      Image

      【GUSHENGTANG HOLDINGS LIMITED Partners with Meituan to Offer Exclusive Health Care for Delivery Riders】

      Recently,GUSHENGTANG HOLDINGS LIMITEDAndMEITUANJointly launched a heartwarming public welfare initiative targeting delivery riders — the "Traditional Chinese Medicine (TCM) X Rider Care Program." This program aims to provide professional TCM health preservation services to riders who tirelessly navigate the streets and alleys of cities. GUSHENGTANG HOLDINGS LIMITED, a nationally renowned TCM chain management group in China, operates over 80 branches across the country with more than 40,000 licensed TCM practitioners, including top-tier talents such as National TCM Masters. Through this collaboration, GUSHENGTANG leverages its professional expertise to offer riders multiple exclusive benefits, including a 40% discount on TCM therapy services covering massage, moxibustion, cupping, and Sanfu herbal patches, helping riders alleviate physical fatigue and discomfort caused by prolonged riding. A relevant representative from Meituan stated,Hope to ensure the health of riders through cooperation with GUSHENGTANG HOLDINGS LIMITED.Currently, this public welfare initiative has been launched in some cities, with more to follow.Zhengzhou, Foshan, Zhongshan, ChengduRiders in other regions will also gradually enjoy this benefit.（GUSHENGTANG HOLDINGS LIMITED Main News)

      Image

      Image
      【Announcement by the National Healthcare Security Administration: Instant Settlement of Medical Insurance Funds】
      Recently, the Office of the National Healthcare Security Administration officially issued the "Operational Guidelines for the Instant Settlement of Basic Medical Insurance Funds (Trial)", which clearly standardizes the entire process of instant medical insurance settlement, providing a unified operational guide for insured individuals seeking medical treatment, medical institutions conducting settlements, and the management of medical insurance funds. The new regulations specify four key aspects:Standardize the use of unified medical treatment certificates, require medical institutions to settle accounts simultaneously upon discharge, clarify the standards and time limits for medical insurance processing, and stipulate that abnormal settlements be investigated and corrected within 3 working days.(National Healthcare Security Administration News)

      【Notice on Standardizing "Self-Media" Medical Popularization Behavior Jointly Issued by Four Departments】

      Recently, the Cyberspace Administration of China, the National Health Commission, the State Administration for Market Regulation, and the National Administration of Traditional Chinese Medicine jointly issued the "Notice on Regulating the Medical Science Communication Behavior of 'Self-Media'". The notice requires websites and platformsImproving the Qualification Recognition of Medical "Self-Media" AccountsCertificateWork, classify and verify the certification of account qualifications, and clearly display the account qualification information,Strictly Label the Sources of Medical Science Communication Information, strictly prohibit unqualified accounts from publishing professional medical science content, and strengthen online behavior standards,Strictly Prohibit Irregular and Disguised Advertising, and severely handle illegal and irregular information and accounts. The notice emphasized that cyberspace, health, and market regulatory authorities at all levels should strengthen their supervision and guidance of website platforms, standardize the medical science popularization behavior of "self-media," and protect the legitimate rights and interests of the public.(Health China News)

      【Notice on Standardizing the Management of Outpatient Department Names in Medical Institutions Issued by Three Departments Including the National Health Commission】】

      Recently, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Disease Control and Prevention Administration jointly issued the "Notice on Standardizing the Management of Outpatient Department Names in Medical Institutions". Medical institutions are required to strictly comply with relevant regulations, scientifically and reasonably set up outpatient names, ensure that the names match the medical subjects, and avoid...UseNames that are vague, general, or easily confusing must not imply efficacy or mislead patients.The notice also mentionsSpecialty Clinic、Multidisciplinary Joint ClinicNamingSpecific Requirements, emphasizing that medical institutions should optimize outpatient management processes to improve the patient experience. Health administrative departments at all levels need to strengthen the supervision and management of outpatient names, incorporating it into the evaluation and verification of medical institutions.(Message from the Department of Medical Administration)

      [The National Financial Regulatory Administration Requires Urban Commercial Medical Insurance to Adhere to Its Commercial Nature and Standardize Precise Pricing]
      Points】

      Recently, the National Financial Regulatory Administration issued the "Notice on Promoting the High-Quality Development of Urban Commercial Medical Insurance," requiring urban commercial medical insurance (Huibao) to emphasize its inclusive positioning, adhere to its commercial nature, follow insurance principles, and ensure standardized and precise pricing. The notice emphasized,Urban commercial medical insurance should optimize product offerings by incorporating new medical technologies, new drugs, and new device applications, providing fair access, reasonable premiums, and effective coverage.At the same time, insurance companies are required to follow market-oriented and rule-of-law principles, adhere to independent operation and voluntary insurance purchase, and ensure that premiums match the level of coverage. In addition, the notice also requires insurance companies to base on the characteristics of different groups for...Differentiated pricing, scientific and accurate pricing.In 2024, IGUSHENGTANG HOLDINGS LIMITEDPremium income from commercial health insurance is close to one trillion yuan, reaching 622.3 billion yuan in the first half of 2025.(ChinaNews from the Certification Network）

      【China's National Healthcare Security Administration Confirms "New Drug Launch Price Mechanism" for the First Time】

      Recently, the National Healthcare Security Administration (NHSA) officially confirmed for the first time that it has formulated a "newly launched drug initial pricing mechanism," covering chemical drugs, biologics, and traditional Chinese medicine. The NHSA will focus on establishing a price stabilization period for innovative drugs and optimizing the online listing process.Give Innovative Pharmaceutical Companies More Pricing Power, while requiring enterprises to bear the obligation of information disclosure. The new mechanism will support high-level innovative drugs in obtaining reasonable returns in the early stage of listing.At the same time, a price stability period protection of 1-5 years is set, and it is temporarily not included in the centralized procurement scope.(Jian Shi Ju News)

      Image

      【WE-LINKING Releases the World's First Customization Platform for Medical-Grade Implantable Brain-Computer Interface Systems】

      Recently, ShenzhenWE-LINKINGTechnology Co., Ltd. AnnouncesPushOutThe world's first custom platform for medical-grade implantable brain-computer interface systems designed specifically for clinical research.This platform features a standardized design process, modular core components, and flexible customization capabilities, aiming to lower the threshold for brain-computer interface research, accelerate its clinical translation and popularization. The platform strictly adheres to the safety standards of implantable medical devices, providing high-quality neural signal acquisition and data transmission performance, supporting multi-center, large-scale clinical research. WE-LINKING promotes the application of brain-computer interface technology in the treatment of neurological diseases by integrating medical and engineering expertise and leveraging industry chain advantages to build a nationwide service network in China.(Arterial Network News)

      [Mayo Clinic Partners with NVIDIA to Deploy Supercomputing Power, Accelerating the Development of Large Medical Models]

      Recently,Mayo ClinicAnnounce withNVIDIACooperation, by deploying the NVIDIA DGX SuperPOD equipped with the NVIDIA DGX B200 system,A crucial step has been taken in integrating AI solutions in clinical settings.This advanced computing infrastructure will first support the development of foundational models in pathology, drug discovery, and precision medicine. The DGX SuperPOD powered by NVIDIA Blackwell is designed for efficient processing of large high-resolution images required for AI foundational model training.Its powerful speed and scalability can significantly reduce the workload time for pathological slide analysis and foundational model development from four weeks to one week.Thereby significantlyImprove Patient Outcomes。(Intelligence Pharmacy Bureau News)

      [Methuselah Completes Over 100 Million Yuan in B+ Round Financing, Boosting R&D and Commercialization of Medical Nutrition Products]】

      Recently,Methuselah(Shanghai) Biotechnology Co., Ltd. announced the completion of a B+ round of financing exceeding 100 million yuan. This round of financing was jointly led by Bailian Commercial Investment and Bailian Zhigao, with existing shareholders Hony Capital and Honspring Capital continuing to increase their investments. WinX Capital continued to serve as the exclusive financial advisor. The funds raised will mainly be used to strengthen R&D investment in core products, advance clinical trials, and consolidate the company's position in..."Leading Advantages in Both Clinical and Consumer Scenarios."Methuselah focuses onMedical Nutrition Field，Have established coverage of specialMedical Purpose Formula Foods, Calorie-Controlled Weight Loss Nutritional Foods, and DGI FoodsThe full-matrix layout has resulted in more than a hundred medical nutrition products, with six special medical formulas and FDA registration qualifications. The company has established specialized R&D centers for special medical foods in Shanghai and Taizhou, promoting full-chain innovation from basic formulations to clinical validation. In terms of commercialization, Masiela has built a collaborative model of "in-depth cultivation within hospitals + expansion outside hospitals," cooperating with more than 30 core hospitals across China.Entering large chain supermarkets and health retail channels simultaneously, promoting the concept of medical nutrition to a broader consumer base.(Arterial Network News)

      [Innare Medical Secures Tens of Millions in Pre-A Funding, Accelerating the Domestic Process of Bone Metabolism Diagnosis and Treatment]

      Recently,INNARuiHealthcareINNORAY Medical (Shanghai) Co., Ltd. Completes Tens of Millions of Yuan in Pre-A Round Financing Led by Chengshu Investment(Artery Network News)

      ImageImage


      Image
      -Advertisement

      Image
       / END /
      // Source of this article: Comprehensive report from Zhen Suo Jie
      ❖Solemn Declaration: The content of this article is for learning and communication only. The views expressed in this article are those of the author and do not necessarily represent those of the original author. The images in this article are based on the CC0 protocol and have been authorized. If you have any questions, please contact the editor.

      Image

      Image
      Image